Ligand Pharmaceuticals Inc (NASDAQ:LGND)

89.67
Delayed Data
As of May 22
 +0.44 / +0.49%
Today’s Change
41.99
Today|||52-Week Range
90.48
+68.52%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 99.50, with a high estimate of 127.00 and a low estimate of 86.00. The median estimate represents a +10.96% increase from the last price of 89.67.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.31
Sales
$14.3M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -48.33%
 
 
 
 
 
 
Growthannually 32.36%
 
 
 
 
 
 

Sales

Growthquarterly -37.82%
 
 
 
 
 
 
Growthannually 27.41%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account